Literature DB >> 2889483

Molecular characterization of chromosome 7 long arm deletions in myeloid disorders.

J Kere1, T Ruutu, R Lahtinen, A de la Chapelle.   

Abstract

Partial deletion of the long arm of chromosome 7 is a common abnormality in the bone marrow cells of patients with myelodysplastic syndrome (MDS) or acute nonlymphocytic leukemia (ANLL). This study was undertaken to characterize the chromosome breakpoints in molecular terms and to determine if hemizygosity or submicroscopic deletions occur in patients without any cytogenetically detectable abnormality of chromosome 7. We studied restriction fragment length polymorphisms with 10 chromosome 7-specific DNA probes in separated WBC fractions. No molecular abnormalities occurred in lymphocyte-derived DNA. Several probes located in band 7q22 or distally thereof detected deletion of one allele in granulocyte-derived DNA from all four patients with chromosome 7 long arm deletion. In the granulocytes of one patient heterozygosity for the T cell receptor beta chain gene (in band 7q35) indicated that the deletion was interstitial. NJ-3, a proalpha2(I)collagen gene probe (in band 7q21-22) detected heterozygosity in the granulocytes of one patient. No hemizygosity or deletions were found in four patients with two normal chromosomes 7. These results confirm that mature granulocytes but not lymphocytes are derived from the abnormal clone. Interstitial deletions exist, and the extent of deleted genomic material varies among patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2889483

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies.

Authors:  Jasmine C Y Wong; Yan Zhang; Kenneth H Lieuw; Mary T Tran; Erna Forgo; Kelley Weinfurtner; Pilar Alzamora; Scott C Kogan; Keiko Akagi; Linda Wolff; Michelle M Le Beau; Nigel Killeen; Kevin Shannon
Journal:  Blood       Date:  2010-03-16       Impact factor: 22.113

2.  Mutational Landscape and Gene Expression Patterns in Adult Acute Myeloid Leukemias with Monosomy 7 as a Sole Abnormality.

Authors:  Ann-Kathrin Eisfeld; Jessica Kohlschmidt; Krzysztof Mrózek; Stefano Volinia; James S Blachly; Deedra Nicolet; Christopher Oakes; Karl Kroll; Shelley Orwick; Andrew J Carroll; Richard M Stone; John C Byrd; Albert de la Chapelle; Clara D Bloomfield
Journal:  Cancer Res       Date:  2016-10-26       Impact factor: 12.701

3.  Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7.

Authors:  K M Shannon; A G Turhan; S S Chang; A M Bowcock; P C Rogers; W L Carroll; M J Cowan; B E Glader; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

4.  Chromosome 7 long arm deletion breakpoints in preleukemia: mapping by pulsed field gel electrophoresis.

Authors:  J Kere
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

5.  Therapy-related myelodysplastic syndrome in children with medulloblastoma following MOPP chemotherapy.

Authors:  A Hayani; D H Mahoney; L D Taylor
Journal:  J Neurooncol       Date:  1992-09       Impact factor: 4.130

6.  Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis.

Authors:  Jasmine C Wong; Kelley M Weinfurtner; Maria Del Pilar Alzamora; Scott C Kogan; Michael R Burgess; Yan Zhang; Joy Nakitandwe; Jing Ma; Jinjun Cheng; Shann-Ching Chen; Theodore T Ho; Johanna Flach; Damien Reynaud; Emmanuelle Passegué; James R Downing; Kevin Shannon
Journal:  Elife       Date:  2015-07-20       Impact factor: 8.140

7.  Allelic imbalances on chromosome 20 in human transitional cell carcinoma.

Authors:  S Higashi; T Habuchi; T Takahashi; T Kamoto; Y Kakehi; O Ogawa; H Hiai
Journal:  Jpn J Cancer Res       Date:  2000-05
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.